The neoplastic CD5/CD19 B cells resulting sensitive to α-BSB were obtained from 45 untreated patients representative of the typical diagnostic characteristics, natural history and clinical outcome of the B-CLL (Table 1). The gene discussed is CD19; the disease is B-cell chronic lymphocytic leukemia.